One argument was that exosomal tumoral miRNAs were derived from live tumor cells contrary to free miRNAs, associated with Argonaute2 protein and derived from dead cells; moreover, exosomes offer the possibility to improve the miRNA diagnosis by joining specific membrane protein biomarkers for diagnosis. This evidence concerns the gene AGO2 and neoplasm.